ClinicalTrials.Veeva

Menu

Cluster Headache and SPINK-1 Gene

P

Public Assistance-Hospitals of Marseille (AP-HM)

Status

Completed

Conditions

Episodic or Chronic Cluster Headache

Treatments

Genetic: blood sample

Study type

Interventional

Funder types

Other

Identifiers

NCT02585739
2011-19
RC12_3011 (Other Identifier)

Details and patient eligibility

About

Cluster headache (CH) is a rare, excruciating primary headache disorder. A genetic basis has been suggested by family and twin studies, but the mode of transmission seems to vary and the amount of heritability is unclear.

The number of genetic association studies investigating variants implicated in the pathophysiology of CH is limited. The HCRTR2 1246G > A and the ADH4 925A > G polymorphisms have been associated with CH. The former has been confirmed and may affect the hypothalamic hypocretin system. The aim of the present study was to investigate the possible link between SPINK 1 gene and cluster headache.

Enrollment

42 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • People aged 18 or over
  • Patient consulting in Marseille's or Nice's Pain departments
  • Patient agreeing to participate to the research study
  • Patient with health insurance

Exclusion criteria

  • People aged under 18
  • Patient refusing to participate to the research study
  • Patient with deprivation of liberty

Trial design

Primary purpose

Screening

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

42 participants in 2 patient groups

patient
Experimental group
Description:
patient with Cluster headache
Treatment:
Genetic: blood sample
healthy subject
Other group
Description:
patient without Cluster headache
Treatment:
Genetic: blood sample

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems